Monogenic Diabetes
Gene: DYRK1B
PMID 38170957 (2024) adds 2 unrelated families with total loss‑of‑function DYRK1B variants (p.R358*; p.H179L) and strong cellular functional evidence; together with prior reports (PMID 34193236, 34786696) the total reaches 6 unrelated families with loss‑of‑function variants causing abdominal obesity‑metabolic syndrome 3. PMID 39192769 adds an additional unrelated case (p.P495L) but shows no functional effect.Created: 6 Apr 2026, 6:01 p.m. | Last Modified: 6 Apr 2026, 6:01 p.m.
Panel Version: 1.4722
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
abdominal obesity-metabolic syndrome 3, MONDO:0014352
Publications
Have reviewed as Amber based on metabolic syndrome phenotype having a significant polygenic contribution, prevalence of reported variants in healthy population databases and inconclusive functional evidence.
PMID 24827035 Keramati et al 2014 NEJM - first reported a heterozygous DYRK1B founder variant (R102C) in 3 Iranian families with early-onset features of metabolic syndrome (central obesity, coronary artery disease, T2DM, hypertension, hypertriglyceridemia). Variant identified by WES and co-segregated with this phenotype in the family. Variant present in gnomad (v2) - 4 hets (European Non-Finnish), 40-45 yo age group. The authors also screened a cohort of 300 morbidly obese Caucasian individuals for this variant and identified heterozygous H90C variant (same exon) in 5 individuals. These individuals also had features of early-onset metabolic syndrome with variant reported to co-segregate with this phenotype in the family. This variant is absent from gnomAD. Functional studies in this study and PMID 28743892 have been inconclusive in clarifying the gene disease mechanism for this variant.
PMID 34193236 Mendoza-Caamal et al 2021 - report 2 unrelated families with heterozygous variants in this gene co-segregating with early-onset metabolic syndrome phenotype. p.Arg252His variant present in 8 hets in gnomAD and p.Lys68Gln in 5 hets.
PMID 34786696 Orenstein et al 2022 report a family with DYRK1B PTC variant associated with metabolic syndrome and abnormal cognition - unable to access this article.Created: 4 May 2022, 12:02 p.m. | Last Modified: 4 May 2022, 12:02 p.m.
Panel Version: 0.23
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Abdominal obesity-metabolic syndrome 3 - MIM#615812
Publications
Gene: dyrk1b has been classified as Green List (High Evidence).
Gene: dyrk1b has been classified as Amber List (Moderate Evidence).
Publications for gene: DYRK1B were set to
Mode of inheritance for gene: DYRK1B was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Gene: dyrk1b has been classified as Amber List (Moderate Evidence).
gene: DYRK1B was added gene: DYRK1B was added to Monogenic diabetes. Sources: Expert Review Green,NHS GMS Mode of inheritance for gene: DYRK1B was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: DYRK1B were set to Metabolic syndrome (coronary artery disease, hypertension, central obesity and diabetes); Abdominal obesity-metabolic syndrome 3, 615812